BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23985697)

  • 1. Vaccinia virus induces programmed necrosis in ovarian cancer cells.
    Whilding LM; Archibald KM; Kulbe H; Balkwill FR; Öberg D; McNeish IA
    Mol Ther; 2013 Nov; 21(11):2074-86. PubMed ID: 23985697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RIP1-dependent and independent effects of necrostatin-1 in necrosis and T cell activation.
    Cho Y; McQuade T; Zhang H; Zhang J; Chan FK
    PLoS One; 2011; 6(8):e23209. PubMed ID: 21853090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIPK3 promotes adenovirus type 5 activity.
    Weigert M; Binks A; Dowson S; Leung EYL; Athineos D; Yu X; Mullin M; Walton JB; Orange C; Ennis D; Blyth K; Tait SWG; McNeish IA
    Cell Death Dis; 2017 Dec; 8(12):3206. PubMed ID: 29238045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia.
    Kim SJ; Li J
    Cell Death Dis; 2013 Jul; 4(7):e716. PubMed ID: 23846218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing therapeutic efficacy of oncolytic vaccinia virus armed with Beclin-1, an autophagic Gene in leukemia and myeloma.
    Lei W; Wang S; Xu N; Chen Y; Wu G; Zhang A; Chen X; Tong Y; Qian W
    Biomed Pharmacother; 2020 May; 125():110030. PubMed ID: 32187960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells.
    Qiu X; Klausen C; Cheng JC; Leung PC
    Cell Death Dis; 2015 Aug; 6(8):e1864. PubMed ID: 26313915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.
    Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA
    PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
    Chen NG; Yu YA; Zhang Q; Szalay AA
    J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccinia virus induces rapid necrosis in keratinocytes by a STAT3-dependent mechanism.
    He Y; Fisher R; Chowdhury S; Sultana I; Pereira CP; Bray M; Reed JL
    PLoS One; 2014; 9(11):e113690. PubMed ID: 25419841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2.
    Guo ZS; Naik A; O'Malley ME; Popovic P; Demarco R; Hu Y; Yin X; Yang S; Zeh HJ; Moss B; Lotze MT; Bartlett DL
    Cancer Res; 2005 Nov; 65(21):9991-8. PubMed ID: 16267024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway.
    Schock SN; Chandra NV; Sun Y; Irie T; Kitagawa Y; Gotoh B; Coscoy L; Winoto A
    Cell Death Differ; 2017 Apr; 24(4):615-625. PubMed ID: 28060376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive roles of receptor-interacting protein kinases 1 and 3 in caspase-independent cell death of L929.
    Park SY; Shim JH; Cho YS
    Cell Biochem Funct; 2014 Jan; 32(1):62-9. PubMed ID: 23584955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.
    Kochneva G; Sivolobova G; Tkacheva A; Grazhdantseva A; Troitskaya O; Nushtaeva A; Tkachenko A; Kuligina E; Richter V; Koval O
    Oncotarget; 2016 Nov; 7(45):74171-74188. PubMed ID: 27708236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fish oil-derived lipid emulsion induces RIP1-dependent and caspase 8-licensed necroptosis in IEC-6 cells through overproduction of reactive oxygen species.
    Yan JK; Yan WH; Cai W
    Lipids Health Dis; 2018 Jun; 17(1):148. PubMed ID: 29935529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Features of the Antitumor Effect of Vaccinia Virus Lister Strain.
    Zonov E; Kochneva G; Yunusova A; Grazhdantseva A; Richter V; Ryabchikova E
    Viruses; 2016 Jan; 8(1):. PubMed ID: 26771631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting intestinal epithelial cell-programmed necrosis alleviates tissue injury after intestinal ischemia/reperfusion in rats.
    Li X; Ling Y; Cao Z; Shen J; Chen S; Liu W; Yuan B; Wen S
    J Surg Res; 2018 May; 225():108-117. PubMed ID: 29605020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models.
    Cecil A; Gentschev I; Adelfinger M; Dandekar T; Szalay AA
    Bioengineered; 2019 Dec; 10(1):190-196. PubMed ID: 31142183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
    Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
    J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.